Standout Papers

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylit... 2003 2026 2010 2018 773
  1. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial (2003)
    John C. Davis, Désirée van der Heijde et al. Arthritis & Rheumatism
  2. Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis (2012)
    Roy Fleischmann, Joel M. Kremer et al. New England Journal of Medicine

Citation Impact

5 by Nobel laureates 23 from Science/Nature 70 standout
Sub-graph 1 of 19

Citing Papers

Regulation of the nucleic acid-sensing Toll-like receptors
2021 Standout
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
2021 Standout

Works of John J. Cush being referenced

RNA recognition by human TLR8 can lead to autoimmune inflammation
2013
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial
2002

Author Peers

Author Rheumatology Hematology Immunology Last Decade Papers Cites
John J. Cush 2469 1130 1561 58 4.2k
Xueshan Gao 11 75
Katrin Serth 5 1 30 13 438
Julian A. Zagalak 2 3 11 8 334
P. C. Chang 34 377
Laurie Geller 1 4 364

All Works

Loading papers...

Rankless by CCL
2026